Dimitris Hatzibougias MD, MSc, PhD
Breast Cancer: Detailed manipulation & advanced techniques for accurate on time diagnosis
Breast cancer is the most common malignancy in women. The overwhelming majority of breast carcinomas appear sporadically and a small percentage of about 20% may have a family-hereditary background. In a clinically defective, emerging or altered feature, it is often indicated to have a needle biopsy performed in the first instance so that it can be identified and interpreted. Under the microscope, the pathologist alone will “baptize” the benign, malignant or suspicious characteristics. Diagnosis & Individualization
Prior to surgery, in the existing material of the first biopsy, the pathologist is most often called, by using Immunohistochemistry method, to highlight the individual profile of the carcinoma. This determines the preoperative, personalized, most prominent prognostic and predictive factors that will predict the biological behavior of the carcinoma and predict the response to targeted therapies that may be given postoperatively.
Hence, the prognosis and predicting response to treatment are determined by the pathologist, which is literally the “Key” medical specialty in breast oncology.
Prior to surgery, in the existing material of the first biopsy, the pathologist is most often called, by using Immunohistochemistry method, to highlight the individual profile of the carcinoma. This determines the preoperative, personalized, most prominent prognostic and predictive factors that will predict the biological behavior of the carcinoma and predict the response to targeted therapies that may be given postoperatively.
Hence, the prognosis and predicting response to treatment are determined by the pathologist, which is literally the “Key” medical specialty in breast oncology.